|
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
|
5-amino-1-(β-D-ribofuranosyl)-1H-imidazole-4-carboxamide
|
|
5-amino-1-β-D-ribofuranosyl-4-imidazolecarboxamide
|
ChemIDplus
|
|
5-amino-1-β-D-ribofuranosylimidazole-4-carboxamide
|
ChemIDplus
|
|
5-amino-1-β-ribofuranosyl-imidazole-4-carboxamide
|
ChemIDplus
|
|
5-amino-1-ribofuranosylimidazole-4-carboxamide
|
ChEBI
|
|
5-amino-1β-D-ribofuranosylimidazole-4-carboxyamide
|
ChemIDplus
|
|
5-amino-4-imidazolecarboxamide ribofuranoside
|
ChemIDplus
|
|
5-aminoimidazole-4-carboxamide ribonucleoside
|
ChemIDplus
|
|
AIC-Riboside
|
ChemIDplus
|
|
AICA-riboside
|
ChemIDplus
|
AICAr
 Note: (2014-05-21) Note that this synonym is case sensitive: AICAr is used to refer to the nucleoside (with a hydroxy group at the 5' position) while AICAR refers to the corresponding nucleotide (i.e. the corresponding 5'-phosphate). |
|
ChEBI
|
|
EC Number 220-097-5
|
ChEBI
|
|
GP 1-110
|
ChemIDplus
|
|
GP-1-110
|
ChemIDplus
|
N1- (β-D-ribofuranosyl)-5-aminoimidazole-4-carboxamide
|
ChEBI
|
